Announcement on Implementation Results of Share Repurchase
Filed with SSE · · 3 pages · Chinese
Nanjing Medlander Medical Technology Co. Ltd. on 6ix
Earlier from Nanjing Medlander Medical Technology
- Announcement on Convening the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Progress in Repurchasing Shares through Call Auction in Phase II
- Report for Q1 2025
- Announcement on Preliminary Earnings Estimate for 2024
Later from Nanjing Medlander Medical Technology
- Announcement on Using Partial Extra Raised Funds to Permanently Supplement Current Capital
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Announcement on Using Partial Temporarily Idle Raised Funds for Cash Management
- Indicative Announcement on the Renewal of the "Common Control Agreement" Between the Controlling Shareholder and Actual Controller, Expiration and Termination of the "Acting-in-Concert Agreement" and Renewal of the "Acting-in-Concert Agreement" by Partial Shareholders, and Change in Equity Interests
Follow Nanjing Medlander Medical Technology into a list and get an email when it puts out news.
Follow Nanjing Medlander Medical Technology